COSAN SA -ADR (CSAN) Stock Fundamental Analysis

NYSE:CSAN • US22113B1035

4.8 USD
-0.16 (-3.23%)
At close: Mar 2, 2026
4.8 USD
0 (0%)
After Hours: 3/2/2026, 8:11:25 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CSAN. CSAN was compared to 123 industry peers in the Specialty Retail industry. There are concerns on the financial health of CSAN while its profitability can be described as average. CSAN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • CSAN had negative earnings in the past year.
  • In the past year CSAN had a positive cash flow from operations.
  • CSAN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CSAN had a positive operating cash flow.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

  • CSAN has a Return On Assets of -9.31%. This is in the lower half of the industry: CSAN underperforms 72.36% of its industry peers.
  • CSAN has a worse Return On Equity (-163.24%) than 73.98% of its industry peers.
  • CSAN has a Return On Invested Capital of 6.48%. This is in the better half of the industry: CSAN outperforms 62.60% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CSAN is significantly below the industry average of 13.61%.
  • The 3 year average ROIC (4.36%) for CSAN is below the current ROIC(6.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROIC 6.48%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • CSAN has a better Operating Margin (20.98%) than 98.37% of its industry peers.
  • In the last couple of years the Operating Margin of CSAN has declined.
  • CSAN's Gross Margin of 31.48% is on the low side compared to the rest of the industry. CSAN is outperformed by 60.98% of its industry peers.
  • In the last couple of years the Gross Margin of CSAN has remained more or less at the same level.
Industry RankSector Rank
OM 20.98%
PM (TTM) N/A
GM 31.48%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSAN is destroying value.
  • CSAN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CSAN has been increased compared to 5 years ago.
  • CSAN has a worse debt/assets ratio than last year.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.80, we must say that CSAN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.80, CSAN is doing worse than 71.54% of the companies in the same industry.
  • The Debt to FCF ratio of CSAN is 17.68, which is on the high side as it means it would take CSAN, 17.68 years of fcf income to pay off all of its debts.
  • CSAN has a Debt to FCF ratio of 17.68. This is comparable to the rest of the industry: CSAN outperforms 50.41% of its industry peers.
  • A Debt/Equity ratio of 8.61 is on the high side and indicates that CSAN has dependencies on debt financing.
  • CSAN has a Debt to Equity ratio of 8.61. This is in the lower half of the industry: CSAN underperforms 78.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Altman-Z 0.8
ROIC/WACC0.9
WACC7.24%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.83 indicates that CSAN should not have too much problems paying its short term obligations.
  • CSAN's Current ratio of 1.83 is fine compared to the rest of the industry. CSAN outperforms 78.05% of its industry peers.
  • A Quick Ratio of 1.68 indicates that CSAN should not have too much problems paying its short term obligations.
  • CSAN's Quick ratio of 1.68 is amongst the best of the industry. CSAN outperforms 86.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.68
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CSAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -872.35%.
  • Looking at the last year, CSAN shows a quite strong growth in Revenue. The Revenue has grown by 11.36% in the last year.
  • Measured over the past years, CSAN shows a very strong growth in Revenue. The Revenue has been growing by 26.51% on average per year.
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%

3.2 Future

  • Based on estimates for the next years, CSAN will show a very strong growth in Earnings Per Share. The EPS will grow by 33.37% on average per year.
  • The Revenue is expected to grow by 1.78% on average over the next years.
EPS Next Y72.43%
EPS Next 2Y49.1%
EPS Next 3Y33.37%
EPS Next 5YN/A
Revenue Next Year-3.69%
Revenue Next 2Y-0.82%
Revenue Next 3Y0.9%
Revenue Next 5Y1.78%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • CSAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 16.63, the valuation of CSAN can be described as correct.
  • 68.29% of the companies in the same industry are more expensive than CSAN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. CSAN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.63
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • 88.62% of the companies in the same industry are more expensive than CSAN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CSAN is valued cheaply inside the industry as 89.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.49
EV/EBITDA 5.57
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CSAN's earnings are expected to grow with 33.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.1%
EPS Next 3Y33.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • CSAN has a Yearly Dividend Yield of 2.44%.
  • CSAN's Dividend Yield is rather good when compared to the industry average which is at 2.33. CSAN pays more dividend than 82.11% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CSAN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

  • On average, the dividend of CSAN grows each year by 25.09%, which is quite nice.
  • CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)25.09%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

  • CSAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of CSAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-25.08%
EPS Next 2Y49.1%
EPS Next 3Y33.37%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

More info and screens

Find the best dividend stocksShow peers with best dividend

COSAN SA -ADR

NYSE:CSAN (3/2/2026, 8:11:25 PM)

After market: 4.8 0 (0%)

4.8

-0.16 (-3.23%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-14
Earnings (Next)03-03
Inst Owners10.91%
Inst Owner Change39.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.75B
Revenue(TTM)43.95B
Net Income(TTM)-11.74B
Analysts78.89
Price Target4.8 (0%)
Short Float %0.1%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.67
Dividend Growth(5Y)25.09%
DP-25.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-812.09%
Min EPS beat(2)-1027.4%
Max EPS beat(2)-596.78%
EPS beat(4)0
Avg EPS beat(4)-744.76%
Min EPS beat(4)-1285.85%
Max EPS beat(4)-69.01%
EPS beat(8)1
Avg EPS beat(8)-367.61%
EPS beat(12)2
Avg EPS beat(12)-257.65%
EPS beat(16)4
Avg EPS beat(16)-198.12%
Revenue beat(2)0
Avg Revenue beat(2)-75.19%
Min Revenue beat(2)-76.92%
Max Revenue beat(2)-73.47%
Revenue beat(4)0
Avg Revenue beat(4)-74.24%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-72.24%
Revenue beat(8)0
Avg Revenue beat(8)-55.64%
Revenue beat(12)0
Avg Revenue beat(12)-51.45%
Revenue beat(16)0
Avg Revenue beat(16)-57.72%
PT rev (1m)-0.45%
PT rev (3m)-17.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-53.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.63
P/S 0.56
P/FCF 6.49
P/OCF 1.94
P/B 3.41
P/tB N/A
EV/EBITDA 5.57
EPS(TTM)-2.01
EYN/A
EPS(NY)0.29
Fwd EY6.01%
FCF(TTM)0.74
FCFY15.42%
OCF(TTM)2.47
OCFY51.54%
SpS8.53
BVpS1.41
TBVpS-3.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROCE 8.21%
ROIC 6.48%
ROICexc 7.59%
ROICexgc 10.52%
OM 20.98%
PM (TTM) N/A
GM 31.48%
FCFM 8.67%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexgc growth 3Y5.58%
ROICexgc growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Debt/EBITDA 4.71
Cap/Depr 221.51%
Cap/Sales 20.32%
Interest Coverage 1.74
Cash Conversion 96.15%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.68
Altman-Z 0.8
F-Score6
WACC7.24%
ROIC/WACC0.9
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
EPS Next Y72.43%
EPS Next 2Y49.1%
EPS Next 3Y33.37%
EPS Next 5YN/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%
Revenue Next Year-3.69%
Revenue Next 2Y-0.82%
Revenue Next 3Y0.9%
Revenue Next 5Y1.78%
EBIT growth 1Y48.56%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year96.25%
EBIT Next 3Y32.07%
EBIT Next 5Y16.44%
FCF growth 1Y-35.46%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y14.86%
OCF growth 3Y35.81%
OCF growth 5Y36.03%

COSAN SA -ADR / CSAN FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSAN.


What is the valuation status for CSAN stock?

ChartMill assigns a valuation rating of 6 / 10 to COSAN SA -ADR (CSAN). This can be considered as Fairly Valued.


How profitable is COSAN SA -ADR (CSAN) stock?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for COSAN SA -ADR?

The Earnings per Share (EPS) of COSAN SA -ADR (CSAN) is expected to grow by 72.43% in the next year.